Found: 36
Select item for more details and to access through your institution.
Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Natural history of multiple myeloma patients refractory to venetoclax: A single center experience.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E68, doi. 10.1002/ajh.26064
- By:
- Publication type:
- Article
Breakthroughs in the Management of Multiple Myeloma.
- Published in:
- Drugs, 2003, v. 63, n. 16, p. 1621, doi. 10.2165/00003495-200363160-00001
- By:
- Publication type:
- Article
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e243, doi. 10.1016/j.clml.2019.09.404
- By:
- Publication type:
- Article
Gain of Chromosome 1q is Associated with Early Progression in Multiple Myeloma Patients Treated with Lenalidomide, Bortezomib, and Dexamethasone.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e76, doi. 10.1016/j.clml.2019.09.121
- By:
- Publication type:
- Article
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and Engraftment Parameters for Bloodless Transplants among Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e68, doi. 10.1016/j.clml.2017.03.124
- By:
- Publication type:
- Article
Survival Outcomes of Younger (≤ 50 years) Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e119, doi. 10.1016/j.clml.2017.03.216
- By:
- Publication type:
- Article
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Managing Chronic Myeloid Leukemia: A Coordinated Team Care Perspective.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 2, p. 88, doi. 10.1016/j.clml.2011.10.004
- By:
- Publication type:
- Article
Prognostic Significance of Leukopenia at the Time of Diagnosis in Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 5, p. 427, doi. 10.1016/j.clml.2011.03.035
- By:
- Publication type:
- Article
Venetoclax ex vivo functional profiling predicts improved progression-free survival.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00710-9
- By:
- Publication type:
- Article
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0254-0
- By:
- Publication type:
- Article
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 5, p. 608, doi. 10.1111/j.1365-2141.2012.09209.x
- By:
- Publication type:
- Article
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 5, p. 677, doi. 10.1111/j.1365-2141.2009.07892.x
- By:
- Publication type:
- Article
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.
- Published in:
- Hematology Reports, 2017, v. 9, n. 3, p. 102, doi. 10.4081/hr.2017.7083
- By:
- Publication type:
- Article
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re‐treatment with daratumumab among refractory patients.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 17, p. 2991, doi. 10.1002/cncr.32178
- By:
- Publication type:
- Article
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and survival outcomes for bloodless transplantation in patients with myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 539, doi. 10.1111/bjh.13637
- By:
- Publication type:
- Article
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predicting early blast transformation in chronic-phase chronic myeloid leukemia: Is immunophenotyping the missing link?
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 6, p. 872, doi. 10.1002/cncr.29142
- By:
- Publication type:
- Article
Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 6, p. 853, doi. 10.1002/cncr.29136
- By:
- Publication type:
- Article
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 21, p. 3784, doi. 10.1002/cncr.28253
- By:
- Publication type:
- Article
Treatment of adults with acute lymphoblastic leukemia: Do the specifics of the regimen matter?: Results from a prospective randomized trial.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Treatment of adults with acute lymphoblastic leukemia: Do the specifics of the regimen matter?
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 6, p. 1186, doi. 10.1002/cncr.27901
- By:
- Publication type:
- Article
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 21, p. 5278, doi. 10.1002/cncr.27494
- By:
- Publication type:
- Article
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 14, p. 3538, doi. 10.1002/cncr.26660
- By:
- Publication type:
- Article
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 428, doi. 10.1002/cncr.26290
- By:
- Publication type:
- Article
Phase 1 Multicenter Study of Vincristine Sulfate Liposomes Injection and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 23, p. 5490, doi. 10.1002/cncr.24632
- By:
- Publication type:
- Article
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1542, doi. 10.3390/jcm9051542
- By:
- Publication type:
- Article
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 10, p. 2171, doi. 10.1002/cncr.21852
- By:
- Publication type:
- Article